DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Ornidazole is an investigational drug.
There have been 7 clinical trials for Ornidazole. The most recent clinical trial was a Phase 2 trial, which was initiated on March 3rd 2018.
The most common disease conditions in clinical trials are Recurrence, Crohn Disease, and Colonic Neoplasms. The leading clinical trial sponsors are Assistance Publique - Hôpitaux de Paris, Haining Health-Coming Biotech Co., Ltd., and University Hospital, Clermont-Ferrand.
There are four hundred and twelve US patents protecting this investigational drug and two international patents.
Recent Clinical Trials for Ornidazole
|Mechanical Bowel Preparation and Oral Antibiotics Before Colon Cancer Surgery||Assistance Publique - Hôpitaux de Paris||Phase 3|
|Mechanical Bowel Preparation and Oral Antibiotics Before Rectal Cancer Surgery||Assistance Publique - Hôpitaux de Paris||Phase 3|
|Metronidazole as an Adjunct of Non- Surgical Treatment of Peri-implantitis||Osteology Foundation||Phase 4|
Top disease conditions for Ornidazole
Top clinical trial sponsors for Ornidazole
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Ornidazole||See Pricing||Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof||The Regents of the University of California (Oakland, CA)||See Pricing|
|Ornidazole||See Pricing||Methods and compositions for treating infection||UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS)||See Pricing|
|Ornidazole||See Pricing||Drug device configured for wireless communication||Pop Test Abuse Deterrent Technology, LLC (Cliffside Park, NJ)||See Pricing|
|Ornidazole||See Pricing||Treatments for gastrointestinal conditions||Board of Regents, The University of Texas System (Austin, TX) St. Jude Children's Research Hospital, Inc. (Memphis, TN)||See Pricing|
|Ornidazole||See Pricing||Boron-containing small molecules as antiprotozoal1 agents||MMV MEDICINES FOR MALARIA VENTURE (Geneva, CH)||See Pricing|
|Ornidazole||See Pricing||Cadotril particles||Johnson & Johnson Consumer Inc. (Skillman, NJ)||See Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Ornidazole||European Patent Office||2981556||2033-04-02||See Pricing|
|Ornidazole||World Intellectual Property Organization (WIPO)||2014165513||2033-04-02||See Pricing|
|Ornidazole||World Intellectual Property Organization (WIPO)||2014052836||2032-09-27||See Pricing|
|Ornidazole||European Patent Office||3151906||2034-06-03||See Pricing|
|Ornidazole||World Intellectual Property Organization (WIPO)||2015187289||2034-06-03||See Pricing|
|Ornidazole||European Patent Office||3116499||2034-03-12||See Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|